Magnera makes the non-woven materials inside everyday products like baby diapers, adult incontinence items, wipes, dryer sheets, tea bags, and medical garments—the hidden fabric layer that absorbs and filters.
Revenue is $3.20B, but gross margin is only 10.96% and net margin is -3.41%, so it loses money. No business line clearly pays the bills; sales come from consumer and healthcare components, but thin pricing and weak profits are the norm.
Magnera's moat is weak: non-woven production is commodity-like, and big buyers like Procter & Gamble, Kimberly-Clark, and Essity can shift orders to other suppliers like Berry Global, Suominen, or Toray, squeezing prices. No proprietary tech or scale advantage
Key events, in time order
Earnings call transcript published; analyst notes resilient model amid cost inflation and positive volume growth.
None yet
None yet
The author believes Magnera's equity is mispriced relative to its credit, suggesting the company is executing well despite appearing distressed.
Main discussion
No comments yet.
Facts and opinions separated · All items sourced · Not investment advice
